Israel Biotech Fund I, L.P.

Insider Reports History

Entity
Company
Location
4 Oppenheimer St., Rehovot, Israel
Signature
/s/ Yuval Cabilly, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Israel Biotech Fund I, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock, par value $0.001 per share 25.1M $10.1M $0.40 Feb 7, 2024 Indirect
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Warrants 13.5M Mar 1, 2024 Indirect
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Convertible Promissory Note 11.2M Mar 1, 2024 Indirect
Ayala Pharmaceuticals, Inc. Director, 10%+ Owner Rights 9.71M Mar 1, 2024 Indirect

Insider Reports Filed by Israel Biotech Fund I, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADXS Ayala Pharmaceuticals, Inc. Mar 1, 2024 6 $0 4 Mar 6, 2024 Director, 10%+ Owner
ADXS Ayala Pharmaceuticals, Inc. Feb 7, 2024 14 $4.54M 4 Feb 12, 2024 Director, 10%+ Owner
ADXS Ayala Pharmaceuticals, Inc. Nov 17, 2023 10 $2.4M 4 Nov 21, 2023 10%+ Owner
ADXS Ayala Pharmaceuticals, Inc. Oct 18, 2023 2 $0 4 Oct 31, 2023 10%+ Owner
ADXS Ayala Pharmaceuticals, Inc. Sep 1, 2023 2 $2M 4/A Sep 29, 2023 10%+ Owner
ADXS Ayala Pharmaceuticals, Inc. Jan 19, 2023 0 $0 3/A Sep 29, 2023 10%+ Owner